Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
97.69
1.21 (1.25%)
At close: Aug 15, 2025, 3:59 PM
97.61
-0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT

Rhythm Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-46.63M -49.5M -43.29M -43.68M -32.26M -141.37M -41.63M -44.16M -46.7M -52.18M -42.49M -40.86M -45M -52.76M -42.87M -35.11M -35.39M 43.75M
Depreciation & Amortization
379K 383K 383K 384K 391K 405K 417K 442K 442K 457K 442K 442K 438K 350K 325K 315K 317K 201K
Stock-Based Compensation
15.88M 12.86M 10.56M 11M 10.36M 7.77M 8.67M 8.61M 8.89M 6.38M 5.29M 4.8M 5.14M 4.61M 4.68M 5.27M 5.67M 5.19M
Other Working Capital
n/a -4.39M -919K 435K 3.76M -1.23M 5.24M 1.03M -1.6M -291K -3.55M -1.32M 4.45M -5.71M -7.47M -7.57M -3.02M 1.65M
Other Non-Cash Items
-849K 3.81M 3.3M 2.74M 11.63M 104.18M 4.13M 3.27M 3.49M 8.5M 2.88M 3.12M -19K -65K -65K -63K -61K -100.06M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -9.88M -235K 135K n/a n/a n/a n/a n/a -7.99M -8.99M -5.02M 22.01M
Change in Working Capital
7.91M -7.91M 10.21M 4.33M -2.15M -2.19M 8.91M 2.83M -7.34M 413K -116K -14.48M 636K -5.76M 5.45M -1.58M 2.65M -4.62M
Operating Cash Flow
-23.31M -40.35M -18.84M -25.21M -29.08M -40.74M -29.38M -29.25M -41.09M -36.43M -34M -46.99M -38.81M -53.63M -40.47M -40.16M -31.84M -33.53M
Capital Expenditures
n/a n/a n/a 40M n/a -40M 1K -1K -875K -47K 1K -95K -4.06M -127K -68K -106K -5.25M -12K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -22.64M n/a 875K n/a n/a 39.6M n/a n/a n/a n/a 5M 100M
Purchase of Investments
-26.95M -33.52M -66.38M -135.62M -66.31M n/a -40.65M -169.19M -75.43M -69.64M -100.42M -101.08M -10.96M -39.48M -68.73M -93.77M -64.93M -297.54M
Sales Maturities Of Investments
80.99M 58.33M 87.53M 45.3M 57.75M 70.05M 63.29M 74.5M 124.5M 92.67M 59.64M 61.48M 51M 112.13M 69.05M 156.66M 83.7M 51.84M
Other Investing Acitivies
n/a n/a n/a n/a -8.56M -40M 22.64M -272K -875K -4.52M n/a -39.6M 36.04M 72.65M 7M 62.89M -5M 100M
Investing Cash Flow
54.03M 24.81M 21.16M -90.82M -8.56M 30.05M 22.64M -94.96M 48.19M 18.46M -40.77M -39.7M 35.98M 72.52M 7.25M 62.78M 13.53M -145.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-2.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
34.96M -1.53M 38.33M 2.49M 146.18M 4.24M 2.42M 73.04M -1.31M -133K 3.23M 41.59M 37.5M 399K 100K 413K 383K 3.85M
Financial Cash Flow
-889K 32.5M 38.33M 2.49M 146.18M 4.24M 2.42M 73.04M -965K -133K 17.36M 158.56M 37.5M 399K 100K 413K 383K 165.59M
Net Cash Flow
29.55M 16.96M 41.62M -113.69M 108.24M -6.65M -4.51M -51.09M 6.02M -18.02M -57.41M 71.88M 34.67M 19.29M -33.12M 23.03M -17.93M -13.66M
Free Cash Flow
-23.31M -40.35M -18.84M 14.79M -29.08M -80.74M -29.38M -29.25M -41.97M -36.48M -34M -47.08M -42.87M -53.76M -40.54M -40.27M -37.09M -33.54M